Brazil expands its anti-AIDS program
(AP) —Brazil's anti-AIDS program will be expanded to include at least 35,000 more people, a Health Ministry official said Wednesday.
Ronaldo Hallal of the ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive anti-retroviral HIV treatment. Before the program's expansion, people with 350 or less CD4 cells per cubic millimeter received treatment.
CD4 cell levels measure the strength of the immune system.
Hallal said recent studies show that the "earlier treatment begins, the better is the quality of life of a person infected with the HIV virus."
"Brazil will be the only large country in the world to offer this kind of treatment that will reduce the risk of opportunistic infections like tuberculosis," Health Minister Alexandre Padilla said in a statement.
The expansion of the program will require spending an additional 120 million reals ($60,000) a year, the Health Ministry said on its website.
Hallal said Brazil already spends 1.2 billion reals ($600 million) each year in its free anti-AIDS program that is currently treating 223,000 people. He said he thinks there are 250,000 other Brazilians infected with the HIV virus but are unaware of it.
Brazil started providing free anti-retroviral drugs and condoms in 1996. To ensure access to cheaper generic medicines to treat the disease, it challenged the patents of major pharmaceutical corporations.
The latest Health Ministry figures available say 241,469 people died of AIDS in Brazil between 1980 and 2010. During the same period, 608,000 AIDS cases were registered.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
New memory for HIV patients
Mar 26, 2012 |
not rated yet |
0
-
New study adds further guidance on when to start antiretroviral therapy for HIV
Sep 26, 2011 |
not rated yet |
0
-
Elite controllers block integration of HIV DNA into host genome
Sep 19, 2011 |
not rated yet |
0
-
Researchers develop quick, cheap HIV/AIDS test
Mar 27, 2007 |
not rated yet |
0
-
Drug designer: New tool reveals mutations that cause HIV-drug resistance
Jul 08, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
HIV & AIDS
16 hours ago |
5 / 5 (3) |
0
|
New microsphere-based methods for detecting HIV antibodies
Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...
HIV & AIDS
May 23, 2013 |
5 / 5 (1) |
0
Fecal microbiota tx feasible for recurrent C. difficile in HIV
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
HIV & AIDS
May 22, 2013 |
not rated yet |
0
Canada lifts ban on gay men donating blood
Canadian health authorities lifted Wednesday what was effectively a ban on gay men giving blood, announcing new rules making men who have not had sex with men in the past five years eligible.
HIV & AIDS
May 22, 2013 |
not rated yet |
1
AIDS scientists optimistic of AIDS cure, for some
Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives—but said it might not work for all people.
HIV & AIDS
May 22, 2013 |
not rated yet |
0
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Depression raises diabetics' risk of severe low blood sugar episodes
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...